FDA Registered Advantage Leverage JCB Laboratories’ and Fagron Sterile Services’ FDA-registered 503B status to target hospitals, clinics, and compounding pharmacies seeking compliant, ready-to-use sterile products with reduced regulatory risk.

Expansion and Capacity capitalize on recent facility expansions in Wichita and the broader FSS network to position as a scalable supplier capable of meeting growing sterility needs and offering faster lead times for custom sterile formulations.

Customizable sterile Highlight the ability to formulate preservative-free products, multiple strengths and sizes, and backorder/discontinuation–proof offerings to target negotiators at hospitals and oncology centers requiring tailored sterile injections.

Technology Enablement Utilize existing tech stack (Power BI, Dynamics, Webflow, Mailchimp) to run data-driven account targeting, personalized outreach, and efficient order management for health care providers seeking reliable sterile supply partners.

Recent Innovations Promote silicone-free bevacizumab injections and other health care product lines as differentiators, appealing to facilities prioritizing advanced manufacturing technologies and reduced extractables/leachables in sterile products.